Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005364736 | SCV006030609 | uncertain significance | Inborn genetic diseases | 2025-03-03 | criteria provided, single submitter | clinical testing | The c.3389A>G (p.N1130S) alteration is located in exon 25 (coding exon 25) of the MED23 gene. This alteration results from a A to G substitution at nucleotide position 3389, causing the asparagine (N) at amino acid position 1130 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |